Spin-out Merge Labs aims to rival Elon Musk’s brain-chip company Neuralink. But researchers say the technology is still at an early stage.

Elon Musk's Neuralink prepares Blindsight implant human trials by 2026, aiming to restore vision for the blind with FDA Breakthrough Device Designation.

OpenAI has invested in Merge Labs, a brain-computer interface startup founded by Sam Altman. The company aims to develop safe, scalable, and non-invasive neural interfaces that allow direct ...

Elon Musk said a third person has received an implant from his brain-computer interface company Neuralink, one of many groups working to connect the nervous system to machines. “We’ve got … three ...

The company began building its Texas facility in 2025.

OpenAI is continuing its push into healthcare by investing in Merge Labs, a brain-computer interface startup co-founded by its CEO, Sam Altman. Merge Labs is a new competitor to Elon Musk’s Neuralink, ...

BENGALURU, Dec 31 (Reuters) - Elon ‌Musk's brain implant company ‌Neuralink will start "high-volume production" of brain-computer interface devices and move to an entirely ‍automated surgical ...

SEVEN paralysed UK patients have had a life-changing brain chip planted in their head allowing them to control a computer ...